These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 8542203
1. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Br J Rheumatol; 1995 Nov; 34(11):1031-6. PubMed ID: 8542203 [Abstract] [Full Text] [Related]
9. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. Roubey RA, Pratt CW, Buyon JP, Winfield JB. J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218 [Abstract] [Full Text] [Related]
10. Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution. Navarro M, Cervera R, Teixidó M, Reverter JC, Font J, López-Soto A, Monteagudo J, Escolar G, Ingelmo M. Br J Rheumatol; 1996 Jun; 35(6):523-8. PubMed ID: 8670571 [Abstract] [Full Text] [Related]
13. Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I. González C, Lestón A, García-Berrocal B, Sánchez-Rodriguez A, Martín-Oterino JA, Alberca I, Cordero M, Jorge R, Navajo JA, González-Buitrago JM. J Clin Lab Anal; 1999 Jun; 13(2):59-64. PubMed ID: 10102133 [Abstract] [Full Text] [Related]
15. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG. Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [Abstract] [Full Text] [Related]
16. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Samarkos M, Davies KA, Gordon C, Loizou S. Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839 [Abstract] [Full Text] [Related]